Sign in

CIK 0001802369 · <br>Emerging growth company

ADARx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ADRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844145188
Phone
858-283-9472
Business address
5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$87,745,772
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$87,745,772. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. George Simeon +$27.2M Director 1 filing
  2. SR ONE CAPITAL MANAGEMENT, LLC +$27.2M 10% owner 1 filing
  3. GORDON CARL L +$16.1M Director 1 filing
  4. ORBIMED ADVISORS LLC +$16.1M Director 1 filing
  5. Chimovits Erez +$1.0M Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −2,000,962 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series B-1 Preferred Stock −769,601 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −564,187 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series A Preferred Stock −7,127,019 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −1,333,975 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series B-1 Preferred Stock −513,067 0
2026-09-28 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −256,448 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +8,908,775 8,908,775
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +1,667,469 10,576,244
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +513,067 11,089,311
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +153,868 11,243,179
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +307,738 307,738
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion +307,738 307,738
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series A Preferred Stock −10,438,412 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series B Preferred Stock −1,953,774 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series B-1 Preferred Stock −601,161 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series C Preferred Stock −180,288 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series C Preferred Stock −360,577 0
2026-09-28 LAV Biosciences Fund V, L.P. 10% owner Conversion · Series C Preferred Stock −360,577 0
2026-09-28 SR ONE CAPITAL MANAGEMENT, LLC 10% owner Conversion +3,334,938 3,334,938

Page 3 of 5 · 94 trades